SEARCH

SEARCH BY CITATION

REFERENCES

  • Ankeny DP,Guan Z,Popovich PG. 2009. B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J Clin Invest 119: 29902999.
  • Baertling F,Kokozidou M,Pufe T,Clarner T,Windoffer R,Wruck CJ,Brandenburg LO,Beyer C,Kipp M. 2010. ADAM12 is expressed by astrocytes during experimental demyelination. Brain Res 1326: 114.
  • Bajramovic JJ,Plomp AC,Goes A,Koevoets C,Newcombe J,Cuzner ML,van Noort JM. 2000. Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: An early event following inflammatory demyelination. J Immunol 164: 43594366.
  • Barouch R,Schwartz M. 2002. Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: Implications for protective autoimmunity. FASEB J 16: 13041306.
  • Bechmann I,Nitsch R. 1997. Astrocytes and microglial cells incorporate degenerating fibers following entorhinal lesion: A light, confocal, and electron microscopical study using a phagocytosis-dependent labeling technique. Glia 20: 145154.
  • Bitsch A,Schuchardt J,Bunkowski S,Kuhlmann T,Brück W. 2000. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123: 11741183.
  • Bö L,Geurts JJ,Ravid R,Barkhof F. 2004. Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis. Neuropathol Appl Neurobiol 30: 106117.
  • Breij EC,Heijnen P,van der Goes A,Teunissen CE,Polman CH,Dijkstra CD. 2006. Myelin flow cytometry assay detects enhanced levels of antibodies to human whole myelin in a subpopulation of multiple sclerosis patients. J Neuroimmunol 176: 106114.
  • Breij EC,Brink BP,Veerhuis R,van den Berg C,Vloet R,Yan R,Dijkstra CD,van der Valk P,Bö L. 2008. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 63: 1625.
  • Brück W. 2005. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol 252: v39.
  • de Groot CJ,Bergers E,Kamphorst W,Ravid R,Polman CH,Barkhof F,van der Valk P. 2001. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: Increased yield of active demyelinating and (p)reactive lesions. Brain 124: 16351645.
  • de Groot CJ,Montagne L,Janssen I,Ravid R,van der Valk P,Veerhuis R. 2000. Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue. Brain Res Brain Res Protoc 5: 8594.
  • de Vos AF,van Meurs M,Brok HP,Boven LA,Hintzen RQ,van der Valk P,Ravid R,Rensing S,Boon L,'t Hart BA,Laman JD. 2002. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol 169: 54155423.
  • Hanayama R,Tanaka M,Miyasaka K,Aozasa K,Koike M,Uchiyama Y,Nagata S. 2004. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304: 11471150.
  • Derfuss T,Parikh K,Velhin S,Braun M,Mathey E,Krumbholz M,Kümpfel T,Moldenhauer A,Rader C,Sonderegger P,Pöllmann W,Tiefenthaller C,Bauer J,Lassmann H,Wekerle H,Karagogeos D,Hohlfeld R,Linington C,Meinl E. 2009. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc Natl Acad Sci U S A 106: 83028307.
  • Ehling R,Lutterotti A,Wanschitz J,Khalil M,Gneiss C,Deisenhammer F,Reindl M,Berger T. 2004. Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis. Mult Scler 10: 601606.
  • Eikelenboom MJ,Petzold A,Lazeron RH,Silber E,Sharief M,Thompson EJ,Barkhof F,Giovannoni G,Polman CH,Uitdehaag BM. 2003. Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy. Neurology 60: 219223.
  • Forooghian F,Cheung RK,Smith WC,O'Connor P,Dosch HM. 2007. Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosis. J Clin Immunol 27: 388396.
  • Frischer JM,Bramow S,Dal-Bianco A,Lucchinetti CF,Rauschka H,Schmidbauer M,Laursen H,Sorensen PS,Lassmann H. 2009. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132: 11751189.
  • Goodin DS,Ebers GC,Johnson KP,Rodriguez M,Sibley WA,Wolinsky JS. 1999. The relationship of MS to physical trauma and psychological stress: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 52: 17371745.
  • Griffiths I,Klugmann M,Anderson T,Yool D,Thomson C,Schwab MH,Schneider A,Zimmermann F,McCulloch M,Nadon N,Nave KA. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280: 16101613.
  • Heins S,Wong PC,Müller S,Goldie K,Cleveland DW,Aebi U. 1993. The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation. J Cell Biol 123: 15171533.
  • Huizinga R,Heijmans N,Schubert P,Gschmeissner S,'t Hart BA,Hermann H,Amor S. 2007. Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice. J Neuropathol Exp Neurol 66: 295304.
  • Huizinga R,Gerritsen W,Heijmans N,Amor S. 2008. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments. Neurobiol Dis 32: 461470.
  • Huizinga R,Hintzen RQ,Assink K,van Meurs M,Amor S. 2009. T-cell responses to neurofilament light protein are part of the normal immune repertoire. Int Immunol 21: 433441.
  • Iglesias A,Bauer J,Litzenburger T,Schubart A,Linington C. 2001. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36: 220234.
  • Kela-Madar N,de Rosbo NK,Ronen A,Mor F,Ben-Nun A. 2009. Autoimmune spread to myelin is associated with experimental autoimmune encephalomyelitis induced by a neuronal protein, beta-synuclein. J Neuroimmunol 208: 1929.
  • Kooi E-J,van Horssen J,Witte ME,Amor S,van der Valk P,Geurts JJG. 2009. Abundant extracellular myelin in the meninges of patients with multiple sclerosis. Neuropathol Appl Neurobiol 35: 283295.
  • Kuhlmann T,Lingfeld G,Bitsch A,Schuchardt J,Brück W. 2002. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125: 22022212.
  • Mahad D,Ziabreva I,Lassmann H,Turnbull D. 2008. Mitochondrial defects in acute multiple sclerosis lesions. Brain 131: 17221735.
  • Mathey EK,Derfuss T,Storch MK,Williams KR,Hales K,Woolley DR,Al-Hayani A,Davies SN,Rasband MN,Olsson T,Moldenhauer A,Velhin S,Hohlfeld R,Meinl E,Linington C. 2007. Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 204: 23632372.
  • Michalak S,Cofta S,Piatek A,Rybacka J,Wysocka E,Kozubski W. 2009. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome. Eur J Med Res 156161.
  • Moalem G,Leibowitz-Amit R,Yoles E,Mor F,Cohen IR,Schwartz M. 1999. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5: 4955.
  • Mutlu L,Brandt C,Kwidzinski E,Sawitzki B,Gimsa U,Mahlo J,Aktas O,Nitsch R,van Zwam M,Laman JD,Bechmann I. 2007. Tolerogenic effect of fiber tract injury: Reduced EAE severity following entorhinal cortex lesion. Exp Brain Res 178: 542553.
  • Nielsen HM,Veerhuis R,Holmqvist B,Janciauskiene S. 2009. Binding and uptake of A beta1–42 by primary human astrocytes in vitro. Glia 57: 978988.
  • Nielsen HM,Mulder SD,Beliën JA,Musters RJ,Eikelenboom P,Veerhuis R. 2010. Astrocytic A beta 1–42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins. Glia 58: 12351246.
  • Nikic I,Merkler D,Sorbara C,Brinkoetter M,Kreutzfeldt M,Bareyre FM,Brück W,Bishop D,Misgeld T,Kerschensteiner M. 2011. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17: 495499.
  • Parnaik R,Raff MC,Scholes J. 2000. Differences between the clearance of apoptotic cells by professional and non-professional phagocytes. Curr Biol 10: 857860.
  • Prineas JW,Kwon EE,Cho ES,Sharer LR. 1984. Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques. Ann N Y Acad Sci 436: 1132.
  • Semra YK,Seidi OA,Sharief MK. 2002. Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability. J Neuroimmunol 122: 132139.
  • Silber E,Semra YK,Gregson NA,Sharief MK. 2002. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology 58: 13721381.
  • Stadelmann C,Wegner C,Brück W. 2011. Inflammation, demyelination, and degeneration—recent insights from MS pathology. Biochim Biophys Acta 1812: 275282.
  • Storch MK,Piddlesden S,Haltia M,Iivanainen M,Morgan P,Lassmann H. 1998. Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination. Ann Neurol 43: 465471.
  • Tanaka T,Ueno M,Yamashita T. 2009. Engulfment of axon debris by microglia requires p38 MAPK activity. J Biol Chem 284: 2162621636.
  • Trabattoni D,Saresella M,Pacei M,Marventano I,Mendozzi L,Rovaris M,Caputo D,Borelli M,Clerici M. 2009. Costimulatory pathways in multiple sclerosis: Distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease. J Immunol. 183: 49844993.
  • Trapp BD,Ransohoff R,Rudick R. 1999. Axonal pathology in multiple sclerosis: Relationship to neurologic disability. Curr Opin Neurol 12: 295302.
  • Tüzün E,Erdag E,Durmus H,Brenner T,Türkoglu R,Kürtüncü M,Lang B,Akman-Demir G,Eraksoy M,Vincent A. 2011. Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis. Neurol India 59: 4750.
  • Vargas ME,Watanabe J,Singh SJ,Robinson WH,Barres BA. 2010. Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury. Proc Natl Acad Sci U S A 107: 1199311998.
  • van der Goes A,Kortekaas M,Hoekstra K,Dijkstra CD,Amor S. 1999. The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages. J Neuroimmunol 101: 6167.
  • van der Goes A,Boorsma W,Hoekstra K,Montagne L,de Groot CJ,Dijkstra CD. 2005. Determination of the sequential degradation of myelin proteins by macrophages. J Neuroimmunol 161: 1220.
  • van Noort JM,Bsibsi M,Gerritsen WH,van der Valk P,Bajramovic JJ,Steinman L,Amor S. 2010. Alpha B-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions. J Neuropathol Exp Neurol 69: 694703.
  • van Zwam M,Huizinga R,Melief MJ,Wierenga-Wolf AF,van Meurs M,Voerman JS,Biber KP,Boddeke HW,Höpken UE,Meisel C,Meisel A,Bechmann I,Hintzen RQ,'t Hart BA,Amor S,Laman JD,Boven LA. 2009. Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and distinct EAE models. J Mol Med 87: 273286.
  • Zhang Y,Da RR,Guo W,Ren HM,Hilgenberg LG,Sobel RA,Tourtellotte WW,Smith MA,Olek M,Gupta S,Robertson RT,Nagra R,Van Den Noort S,Qin Y. 2005. Axon-reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis. J Clin Immunol 25: 254264.